Nissan Chemical (NNCHY)
(Delayed Data from OTC)
$37.78 USD
+0.51 (1.37%)
Updated Oct 11, 2024 02:34 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nissan Chemical Corporation Unsponsored ADR falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 1,564 | 1,688 | 1,851 | 1,966 | 1,903 |
Cost Of Goods | 841 | 897 | 951 | 1,141 | 1,126 |
Gross Profit | 723 | 790 | 900 | 825 | 777 |
Selling & Adminstrative & Depr. & Amort Expenses | 390 | 403 | 446 | 425 | 421 |
Income After Depreciation & Amortization | 333 | 387 | 454 | 400 | 356 |
Non-Operating Income | 28 | 34 | 29 | 28 | 23 |
Interest Expense | 4 | 2 | 1 | 1 | 1 |
Pretax Income | 357 | 419 | 482 | 428 | 377 |
Income Taxes | 94 | 112 | 134 | 113 | 93 |
Minority Interest | 1 | 2 | 3 | 0 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 264 | 306 | 348 | 315 | 284 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 262 | 304 | 345 | 315 | 283 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 428 | 468 | 545 | 498 | 453 |
Depreciation & Amortization (Cash Flow) | 95 | 81 | 91 | 98 | 97 |
Income After Depreciation & Amortization | 333 | 387 | 454 | 400 | 356 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 139.41 | 141.02 | 142.62 | 144.44 | 146.50 |
Diluted EPS Before Non-Recurring Items | 1.88 | 2.12 | 2.39 | 2.08 | 1.87 |
Diluted Net EPS (GAAP) | 1.88 | 2.16 | 2.42 | 2.18 | 1.93 |
Fiscal Year end for Nissan Chemical Corporation Unsponsored ADR falls in the month of March .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 375.60 | 480.61 | 336.29 | 351.14 |
Cost Of Goods | NA | 190.34 | NA | NA | NA |
Gross Profit | NA | 185.27 | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 92.93 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 92.34 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | 11.42 | NA | NA | NA |
Interest Expense | NA | 1.16 | NA | NA | NA |
Pretax Income | NA | 102.59 | NA | NA | NA |
Income Taxes | NA | 27.83 | NA | NA | NA |
Minority Interest | NA | 0.57 | NA | NA | NA |
Investment Gains/Losses | NA | 0.00 | NA | NA | NA |
Other Income/Charges | NA | 0.00 | NA | NA | NA |
Income From Cont. Operations | NA | 74.75 | 84.23 | 43.85 | 46.08 |
Extras & Discontinued Operations | NA | 0.00 | -3.01 | 0.00 | 4.17 |
Net Income (GAAP) | NA | 74.18 | 81.22 | 43.85 | 50.25 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 138.34 | 138.95 | 139.34 | 139.23 |
Diluted EPS Before Non-Recurring Items | NA | 0.54 | 0.60 | 0.31 | 0.33 |
Diluted Net EPS (GAAP) | NA | 0.54 | 0.58 | 0.31 | 0.36 |